Joanne B Weidhaas (Joanne Weidhaas)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 5

Top Topics

Genome Wide Association

Childhood Cancer

Long Noncoding Rna

Top Venues

Cancer research communications

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Joanne B Weidhaas, Chen Hu, Ritsuko Komaki, Gregory A Masters, George R Blumenschein, Joe Y Chang, Bo Lu, Adam P Dicker, Jeffrey A Bogart, Yolanda I Garces, Samir Narayan, Clifford G Robinson, Vivek S Kavadi, Joel S Greenberger, Christopher D Koprowski, James W Welsh, Elizabeth M Gore, Robert M MacRae, Rebecca Paulus, Jeffrey Bradley
The inherited KRAS-variant as a biomarker of Cetuximab Response in NSCLC. Cancer research communications (2023)
Zirong Li, Ann C Raldow, Joanne B Weidhaas, Qichao Zhou, X Sharon Qi
Prediction of Radiation Treatment Response for Locally Advanced Rectal Cancer via a Longitudinal Trend Analysis Framework on Cone-Beam CT. Cancers 15 (21) (2023)
Joanne B Weidhaas, Nicholas Marco, Aaron W Scheffler, Anusha Kalbasi, Kirk Wilenius, Emily Rietdorf, Jaya Gill, Mara Heilig, Caroline Desler, Robert K Chin, Tania Kaprealian, Susan McCloskey, Ann Raldow, Naga P Raja, Santosh Kesari, Jose Carrillo, Alexandra Drakaki, Mark Scholz, Donatello Telesca
Germline biomarkers predict toxicity to anti-PD1/PDL1 checkpoint therapy. Journal for immunotherapy of cancer 10 (2) (2022)
Poonam Malhotra, Graham H Read, Joanne B Weidhaas
Breast Cancer and miR-SNPs: The Importance of miR Germ-Line Genetics. Non-coding RNA 5 (1) (2019)
Ye Yuan, Joanne B Weidhaas
Functional microRNA binding site variants. Molecular oncology 13 (1) (2018)